Gamma-hydroxybutyrate (GHB)-deficiency in alcohol-dependence?

Alcohol and Alcoholism

Volumn 42, Issue 5, 2007, Pages 506-

  Ameisen, Olivier ^a  

^a NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 HYDROXYBUTYRIC ACID; ALCOHOL; BACLOFEN; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; MEPROBAMATE;

ALCOHOLISM; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DYSPHORIA; GABAERGIC SYSTEM; HUMAN; HYPNOSIS; NONHUMAN; NOTE; PRIORITY JOURNAL; SEDATION; SOMNOLENCE; TRANQUILIZING ACTIVITY; WITHDRAWAL SYNDROME;

ALCOHOLISM; BACLOFEN; GABA AGONISTS; HUMANS; SODIUM OXYBATE;

EID: 35348964238     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agm058     Document Type: Note

References (16)

1. Addolorato, G., Caputo, F., Capristo, E. et al. (2002) Baclofen efficacy in reducing alcohol craving and intake: A preliminary double-blind randomized controlled study. Alcohol and Alcoholism 37, 504-508.
2. Addolorato, G., Leggio, L., Abenavoli, L. et al. (2006) Baclofen in the treatment of alcohol withdrawal syndrome: A comparative study vs diazepam. American Journal of Medicine 119, 276.el3-8.
3. Ameisen, O. (2005) Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: A self-case report of a physician. Alcohol and Alcoholism 40, 147-150.
4. Andriamampandry, C., Taleb, O., Kemmel, V. et al. (2007) Cloning and functional characterization of a gamma-hydroxybutyrate receptor identified in the human brain. FASEB J. 3, 885-895.
5. Breslow, M. F., Fankhauser, M. P., Potter, R. L. et al. (1989) Role of gamma-aminobutyric acid in antipanic drug efficacy. American Journal of Psychiatry 146, 353-356.
6. Bucknam, W. (2007) Suppression of symptoms of alcohol dependence and craving using high-dose baclofen. Alcohol and Alcoholism 42, 158-160.
7. Caputo, F., Addolorato, G. and Lorenzini, F. (2003) Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: An open randomized comparative study. Drug and Alcohol Dependence 70 85-91.
8. Car, H. and Wisniewska, R. J. (2006) Effects of baclofen and L-AP4 in passive avoidance test in rats after hypoxia-induced amnesia. Pharmacological Reports 58, 91-100.
9. Carai, M. A., Colombo, G., Brunetti, G. et al. (2001) Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid. European Journal of Pharmacology 428 315-321.
10. Carai, M. A., Vacca, G., Serra, S. et al. (2004) Suppression of GABA(B) receptor function in vivo by disulfide reducing agent, DL-dithiothreitol (DTT). Psychopharmacology 174, 283-290.
11. Dalvi, A. and Rodgers, R. J. (1996) GABAergic influences on plusmaze behaviour in mice. Psychopharmacology 128, 380-397.
12. Drake, R. G., Davis, L. L., Cates, M. E. et al. (2003) Baclofen treatment for chronic posttraumatic stress disorder. Annals of Pharmacotherapy 37, 1177-1181.
13. Humeniuk, R. E., White, J. M. and Ong, J. (1994) The effects of GABAB ligands on alcohol withdrawal in mice. Pharmacology Biochemistry and Behavior 49, 561-566.
14. Krupitsky, E. M., Burakov, A. M., Ivanov, V. B. et al. (1993) Baclofen administration for the treatment of affective disorders in alcoholic patients. Drug and Alcohol Dependence 33, 157-163.
15. Nava, F., Premi, S., Manzato, E. and Lucchini, A. (2006) Comparing treatments of alcoholism on craving and biochemical measures of alcohol consumption. Journal of Psychoactive Drugs 38, 211-217.
16. Schweitzer, P., Roberto, M. and Madamba, S. G. (2004) Gamma-hydroxybutyrate increases a potassium current and decreases the H-current in hippocampal neurons via GABAB receptors. Journal of Pharmacology and Experimental Therapeutics 311, 172-179.